These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 10938049)

  • 1. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
    Adler AI; Stratton IM; Neil HA; Yudkin JS; Matthews DR; Cull CA; Wright AD; Turner RC; Holman RR
    BMJ; 2000 Aug; 321(7258):412-9. PubMed ID: 10938049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
    Stratton IM; Adler AI; Neil HA; Matthews DR; Manley SE; Cull CA; Hadden D; Turner RC; Holman RR
    BMJ; 2000 Aug; 321(7258):405-12. PubMed ID: 10938048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):703-13. PubMed ID: 9732337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):713-20. PubMed ID: 9732338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
    Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR
    N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment: A Prospective Cohort Study.
    Laugesen E; Knudsen ST; Hansen KW; Rossen NB; Jensen LO; Hansen MG; Munkholm H; Thomsen KK; Søndergaard H; Bøttcher M; Raungaard B; Madsen M; Hulman A; Witte D; Bøtker HE; Poulsen PL
    Hypertension; 2016 Sep; 68(3):768-74. PubMed ID: 27402917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants.
    Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
    Diabetes Obes Metab; 2018 Jun; 20(6):1499-1502. PubMed ID: 29424469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients.
    J Hypertens; 1993 Mar; 11(3):319-25. PubMed ID: 8387090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
    Adamsson Eryd S; Gudbjörnsdottir S; Manhem K; Rosengren A; Svensson AM; Miftaraj M; Franzén S; Björck S
    BMJ; 2016 Aug; 354():i4070. PubMed ID: 27492939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Matthews DR; Stratton IM; Aldington SJ; Holman RR; Kohner EM;
    Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes.
    Herrmann M; Sullivan DR; Veillard AS; McCorquodale T; Straub IR; Scott R; Laakso M; Topliss D; Jenkins AJ; Blankenberg S; Burton A; Keech AC;
    Diabetes Care; 2015 Mar; 38(3):521-8. PubMed ID: 25524951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register.
    Svensson MK; Afghahi H; Franzen S; Björk S; Gudbjörnsdottir S; Svensson AM; Eliasson B
    Diab Vasc Dis Res; 2017 May; 14(3):226-235. PubMed ID: 28467201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86).
    Maddaloni E; Coleman RL; Agbaje O; Buzzetti R; Holman RR
    Lancet Diabetes Endocrinol; 2020 Mar; 8(3):206-215. PubMed ID: 32032540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial.
    Ali MK; Singh K; Kondal D; Devarajan R; Patel SA; Menon VU; Varthakavi PK; Vishwanathan V; Dharmalingam M; Bantwal G; Sahay RK; Masood MQ; Khadgawat R; Desai A; Prabhakaran D; Narayan KMV; Tandon N
    PLoS Med; 2024 Jun; 21(6):e1004335. PubMed ID: 38829880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
    Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular disease: what does the UKPDS tell us about diabetic retinopathy?
    Kohner EM
    Diabet Med; 2008 Aug; 25 Suppl 2():20-4. PubMed ID: 18717974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
    Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
    Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
    Stratton IM; Cull CA; Adler AI; Matthews DR; Neil HA; Holman RR
    Diabetologia; 2006 Aug; 49(8):1761-9. PubMed ID: 16736131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.
    Kelly PJ; Clarke PM; Hayes AJ; Gerdtham UG; Cederholm J; Nilsson P; Eliasson B; Gudbjornsdottir S
    Diabet Med; 2014 Aug; 31(8):954-62. PubMed ID: 24750341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.